Target intelligence / Profile preview

Dystrophin mRNA

Molecular classification
Other (mature messenger RNA), Precursor-messenger RNA (pre-mRNA)
01

Overview

Dystrophin mRNA is a large (~14 kb) mature messenger RNA transcribed from the human *DMD* gene located on chromosome Xp21. It serves as the template for synthesis of full-length and various shorter isoforms of the cytoskeletal protein **dystrophin**, which plays an essential role in stabilizing muscle cell membranes by linking cytoskeletal actin filaments to extracellular matrix components via associated glycoproteins. Mutations affecting either transcription, processing, or translation lead directly to severe neuromuscular diseases such as Duchenne muscular dystrophy. Therapeutic strategies have been developed that specifically target aberrant *DMD* pre-mRNAs using antisense oligonucleotides—these drugs bind specific exons within precursor transcripts and promote their exclusion during splicing ("exon skipping"), thereby restoring partial function even when frameshift mutations are present.

Other names
DMD transcriptDMD pre-mRNAMessenger RNA of dystrophin
02

Mechanism of action

Drugs targeting this molecule generally act by: Binding specific sequences on pre-messenger RNA to modify splicing patterns and restore an open reading frame, enabling production of partially functional truncated proteins in patients with certain mutations.

03

Biological functions

Template for translation of dystrophin proteinRegulation of alternative splicing and isoform diversityMediator in genetic therapies targeting exon skipping
04

Disease associations

Muscular dystrophy, especially Duchenne muscular dystrophy and Becker muscular dystrophyCardiomyopathy associated with DMD mutations
05

Safety considerations

Off-target effects on other RNAs due to sequence similarityImmune reactions against newly produced truncated proteinsLimited efficacy depending on mutation type and tissue delivery efficiency
06

Interacting drugs

Eteplirsen

1 more in the full profile.

07

Biomarkers

Levels of correctly spliced or skipped *DMD* transcripts in muscle biopsies or blood samplesRestoration/production of truncated but functional forms of the protein as measured by Western blot or immunohistochemistry

Beyond the preview

Go deeper on Dystrophin mRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophin mRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call